BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 2878044)

  • 1. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
    Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
    J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies of the role of transforming growth factor-beta in human B cell function.
    Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
    J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
    Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
    J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
    Kumar A; Rogers T; Maizel A; Sharma S
    J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
    Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
    J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
    Petit-Koskas E; Génot E; Lawrence D; Kolb JP
    Eur J Immunol; 1988 Jan; 18(1):111-6. PubMed ID: 3257917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation.
    Ehrhardt RO; Strober W; Harriman GR
    J Immunol; 1992 Jun; 148(12):3830-6. PubMed ID: 1602131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
    Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
    J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
    Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
    Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation.
    Murakawa Y; Strober W; James SP
    J Immunol; 1991 Jan; 146(1):40-6. PubMed ID: 1701799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
    Hébert CD; Birnbaum LS
    Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors.
    Tang J; Nuccie BL; Ritterman I; Liesveld JL; Abboud CN; Ryan DH
    J Immunol; 1997 Jul; 159(1):117-25. PubMed ID: 9200446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.
    Rook AH; Kehrl JH; Wakefield LM; Roberts AB; Sporn MB; Burlington DB; Lane HC; Fauci AS
    J Immunol; 1986 May; 136(10):3916-20. PubMed ID: 2871107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
    J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.
    Nakagawa N; Nakagawa T; Volkman DJ; Ambrus JL; Fauci AS
    J Immunol; 1987 Feb; 138(3):795-801. PubMed ID: 3100616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.